Financial Performance - Total revenue for the three months ended December 31, 2021, was HKD 2,339,000, a decrease of 39.1% compared to HKD 3,843,000 for the same period in 2020[6]. - Total revenue for the nine months ended December 31, 2021, was HKD 5,764,000, down 61.0% from HKD 14,777,000 in the same period of 2020[6]. - Commission income from securities trading and brokerage services for the three months was HKD 730,000, a decline of 53.6% from HKD 1,572,000 in 2020[6]. - Interest income from margin and loan financing services for the nine months was HKD 3,277,000, a decrease of 39.2% compared to HKD 5,403,000 in 2020[6]. - Total revenue for the three months ended December 31, 2021, was HKD 2,339,000, a decrease of 39% compared to HKD 3,843,000 for the same period in 2020[16]. - Revenue from securities trading and brokerage services for the nine months ended December 31, 2021, was HKD 2,310,000, down 62% from HKD 6,144,000 in 2020[16]. - Interest income from margin financing services increased to HKD 2,180,000 for the nine months ended December 31, 2021, compared to HKD 3,508,000 in 2020, reflecting a decrease of 38%[16]. - Total revenue for Q3 2021 was approximately HKD 5.8 million, a decrease of about 61.0% compared to HKD 14.8 million in Q3 2020[32][35]. - Commission income from securities trading and brokerage services fell by approximately 62.4% to about HKD 2.3 million in Q3 2021 from HKD 6.1 million in Q3 2020[30][35]. - Interest income from margin and loan financing services decreased by approximately 39.3% to HKD 3.3 million in Q3 2021 from HKD 5.4 million in Q3 2020[31][35]. Losses and Equity - The company reported a loss before tax of HKD 1,874,000 for the three months, compared to a loss of HKD 3,928,000 in the same period of 2020[6]. - Basic loss per share for the nine months ended December 31, 2021, was HKD 0.43, compared to HKD 0.53 for the same period in 2020[6]. - Total comprehensive loss attributable to owners of the company for the nine months was HKD 8,342,000, compared to HKD 10,553,000 in 2020[7]. - The company reported a net loss attributable to owners of HKD 8,656,000 for the nine months ended December 31, 2021, compared to a loss of HKD 10,553,000 in 2020, indicating an improvement of 18%[28]. - The company's total equity as of December 31, 2021, was HKD 169,783,000, down from HKD 183,599,000 as of December 31, 2020[7]. - The company recorded a loss of approximately HKD 8.7 million in Q3 2021, an improvement from a loss of HKD 10.6 million in Q3 2020[39]. Expenses - Employee costs for the nine months ended December 31, 2021, totaled HKD 6,717,000, a decrease of 50% from HKD 13,362,000 in 2020[21]. - Other operating expenses for the nine months ended December 31, 2021, were HKD 4,510,000, down 46% from HKD 8,295,000 in 2020[22]. - The company reported a significant reduction in commission expenses, totaling HKD 961,000 for the nine months ended December 31, 2021, down 55% from HKD 2,118,000 in 2020[20]. - The company’s financing costs for the nine months ended December 31, 2021, were HKD 137,000, compared to HKD 114,000 in 2020, reflecting a slight increase of 20%[24]. Dividends and Shareholder Information - The company did not declare any dividends during the nine months ended December 31, 2021[7]. - The company did not declare any dividends for the nine months ended December 31, 2021, consistent with the previous year[25]. - As of December 31, 2021, major shareholders include 1,199,640,000 shares (59.98%) held by the controlled corporation of Mr. Huo and Ms. Xie[51]. - The company has a total of 300,000,000 shares (15.00%) held by Ju Zhi Group Limited, which is fully owned by Dr. Li[53]. - The company has not issued any stock options under the stock option plan adopted on December 5, 2016, as of the report date[56]. - There were no purchases, sales, or redemptions of the company's listed securities during the reporting period[57]. Corporate Governance and Management - The company continues to focus on its core services, including securities trading, underwriting, and asset management[9]. - The role of the CEO has been vacant since December 14, 2020, and the board is actively seeking a suitable candidate for this position[63]. - The audit committee consists of three independent non-executive directors, with Mr. Tang serving as the chairman[64]. - The management has reviewed the unaudited consolidated results for the period and confirmed compliance with applicable accounting standards and GEM Listing Rules[66]. - The board of directors has confirmed compliance with the trading standards set forth in GEM Listing Rules during the reporting period[59]. - The company has adhered to the corporate governance code as per GEM Listing Rules, with the exception of deviations from rules A.2.1 and A.6.7[63]. - The company has not disclosed any new product developments or market expansion strategies in the report[60]. - Dr. Li resigned from his positions as executive director and chairman of the board on October 12, 2021[62]. - Mr. Huo's monthly salary increased to HKD 106,000 effective from August 8, 2021[62]. - The company appointed Mr. Tang and Mr. Guan as new members of the board during the reporting period[61]. Client and Asset Management - As of December 31, 2021, the company had no asset management clients, down from two clients as of December 31, 2020[36]. - The net asset value managed by the company was zero as of December 31, 2021, compared to approximately HKD 6.1 billion as of December 31, 2020[36]. - The company's current assets amounted to approximately HKD 157.6 million as of December 31, 2021, compared to HKD 175.1 million as of December 31, 2020[41]. - The current ratio was approximately 5.4 times as of December 31, 2021, up from 3.4 times as of December 31, 2020[41]. - The number of active securities trading accounts decreased to 295 in Q3 2021 from 432 in Q3 2020[30].
PF GROUP(08221) - 2022 Q3 - 季度财报